Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Lendify has secured new financing of up to SEK 1,000,000,000 from, amongst others, Insight Investment
Mandate

Lendify has secured new financing of up to SEK 1,000,000,000 from, amongst others, Insight Investment

October 22, 2020 Banking and Finance M&A Financial Regulatory

Together with, amongst others, the management of the company, the arranger and legal advisors to the arranger, Vinge has acted for Lendify in the structuring, documenting and execution of the transaction where one of the world’s largest and most well established asset managers, Insight Investment, acted as main investor.

The transaction is reported under the EU securitisation regulation (Regulation (EU) 2017/2402 of the European Parliament and of the Council of 12 December 2017) and is subject to the reporting requirements thereunder.

Vinge’s team mainly consisted of Albert Wållgren, Lionardo Ojeda, Axel Jansson and Rebecka Målquist (Banking and Finance) and Emma Stuart Beck, Caroline Krassén, Lave White (Financial Services) and Hanna Risberg (M&A).

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025